Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-tao Liu

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Investigational New Drugs|February 2, 2019
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trialJian-Chun Duan, Zhi-Jie Wang, Lin Lin, et al.
Neurobiology of Aging|December 26, 2015
CHCHD2 gene mutations in familial and sporadic Parkinson's diseaseChang-He Shi, Cheng-Yuan Mao, Shu-Yu Zhang, et al.
The International Journal of Neuroscience|December 9, 2015
Exome capture sequencing identifies a novel CCM1 mutation in a Chinese family with multiple cerebral cavernous malformationsCheng-Yuan Mao, Jing Yang, Shu-Yu Zhang, et al.
Anatomical Record (Hoboken, N.J. : 2007)|July 10, 2013
Distribution of transglutaminase 6 in the central nervous system of adult miceYu-Tao Liu, Bei-Sha Tang, Wei Lan, et al.
Journal of Cancer|October 12, 2019
Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKIYu-Tao Liu, Kai Zhang, Cheng-Cheng Li, et al.
Parkinsonism & Related Disorders|November 6, 2016
SMPD1 variants in Chinese Han patients with sporadic Parkinson's diseaseCheng-Yuan Mao, Jing Yang, Hui Wang, et al.
Chinese Medical Journal|January 31, 2015
Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label studySong Tan, Rui-Hao Wang, Hui-Xia Niu, et al.
Cancer Management and Research|July 2, 2020
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled TrialYu-Tao Liu, Xue-Zhi Hao, De-Ruo Liu, et al.
Thoracic Cancer|May 10, 2021
Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patientsLi-Ling Huang, Xing-Sheng Hu, Yan Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2023
Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical OutcomesChang Lu, Xue-Wu Wei, Zhen Wang, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Investigational New Drugs|February 2, 2019
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trialJian-Chun Duan, Zhi-Jie Wang, Lin Lin, et al.
Neurobiology of Aging|December 26, 2015
CHCHD2 gene mutations in familial and sporadic Parkinson's diseaseChang-He Shi, Cheng-Yuan Mao, Shu-Yu Zhang, et al.
The International Journal of Neuroscience|December 9, 2015
Exome capture sequencing identifies a novel CCM1 mutation in a Chinese family with multiple cerebral cavernous malformationsCheng-Yuan Mao, Jing Yang, Shu-Yu Zhang, et al.
Anatomical Record (Hoboken, N.J. : 2007)|July 10, 2013
Distribution of transglutaminase 6 in the central nervous system of adult miceYu-Tao Liu, Bei-Sha Tang, Wei Lan, et al.
Journal of Cancer|October 12, 2019
Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKIYu-Tao Liu, Kai Zhang, Cheng-Cheng Li, et al.
Parkinsonism & Related Disorders|November 6, 2016
SMPD1 variants in Chinese Han patients with sporadic Parkinson's diseaseCheng-Yuan Mao, Jing Yang, Hui Wang, et al.
Chinese Medical Journal|January 31, 2015
Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label studySong Tan, Rui-Hao Wang, Hui-Xia Niu, et al.
Cancer Management and Research|July 2, 2020
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled TrialYu-Tao Liu, Xue-Zhi Hao, De-Ruo Liu, et al.
Thoracic Cancer|May 10, 2021
Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patientsLi-Ling Huang, Xing-Sheng Hu, Yan Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2023
Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical OutcomesChang Lu, Xue-Wu Wei, Zhen Wang, et al.
Pageof 7